8:01 AM ET
10-Q
Financial Results
Cardio Diagnostics Holdings Q3 2026 Results: Net Loss of $1.73M, Loss Widens
Cardio Diagnostics Holdings, Inc. reported a net loss of $5,021,957 for the nine months ended September 30, 2026, compared to $5,032,799 in the prior year period. Revenue remains minimal at $11,630 for the nine-month period, while the company maintains a cash balance of $3,942,882 following a common stock issuance that raised approximately $3.69 million.
- Key figure
- Net loss $1.73M